The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs
Open accessAbstract
Nicotine dependence is one of the world's leading causes of preventable death. To discover genetic variants that influence risk for nicotine dependence, we targeted over 300 candidate genes and analyzed 3713 single nucleotide polymorphisms (SNPs) in 1050 cases and 879 controls. The Fagerström test for nicotine dependence (FTND) was used to assess dependence, in which cases were required to have an FTND of 4 or more. The control criterion was strict: control subjects must have smoked at least 100 cigarettes in their lifetimes and had an FTND of 0 during the heaviest period of smoking. After correcting for multiple testing by controlling the false discovery rate, several cholinergic nicotinic receptor genes dominated the top signals. The strongest association was from an SNP representing CHRNB3, the beta3 nicotinic receptor subunit gene (P = 9.4 x 10(-5)). Biologically, the most compelling evidence for a risk variant came from a non-synonymous SNP in the alpha5 nicotinic receptor subunit gene CHRNA5 (P = 6.4 x 10(-4)). This SNP exhibited evidence of a recessive mode of inheritance, resulting in individuals having a 2-fold increase in risk of developing nicotine dependence once exposed to cigarette smoking. Other genes among the top signals were KCNJ6 and GABRA4. This study represents one of the most powerful and extensive studies of nicotine dependence to date and has found novel risk loci that require confirmation by replication studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It has been shown that allelic variation in the α5/α3/β4 nAChR subunit gene cluster located in chromosome region 15q25 significantly increases risk of tobacco addiction (Saccone et al. 2007;Berrettini et al. 2008;Lips et al. 2010).”
From Mechanisms of Nicotine Addiction (2021) · cites this paper as Saccone et al. 2007
In the citing paper
“The most compelling evidence for risk variants contributing to smoking behavior was in the CHRNA5/A3/B4 gene cluster, which encodes the α5, α3, and β4 subunits.”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [91]
In the citing paper
“The most thoroughly investigated and replicated finding to date is the association with rs16969968, in CHRNA5 (91).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [91]
In the citing paper
“A second signal in the CHRNA5/A3/B4 cluster is tagged by SNP rs578776; it is strongly associated with nicotine dependence and has a low correlation with rs16969968 (r2 = 0.18), indicating that it represents a statistically independent signal (90,91).”
From Nicotine is a selective pharmacological chaperone of acetylcholine receptor number and stoichiometry. Implications for drug discovery (2009) · cites this paper as [91]
In the citing paper
“With regard to the latter factors, initiation of smoking behavior and transition to dependence (i.e. persistent smoking) has been found to show strong heritability (60). The reported heritability coefficients range from 30% to greater than 80% (a mean of approximately 60% for initiation and 70% for progression to dependence).”
From Tobacco addiction (2008) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Inference of Population Structure Using Multilocus Genotype Data
Pritchard, J. K., Stephens, M., & Donnelly, P. (2000) · Genetics · doi:10.1093/genetics/155.2.945 · Cited by 33,871
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,551
The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
HEATHERTON, T. F., KOZLOWSKI, L. T., FRECKER, R. C., & FAGERSTROM, K. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01879.x · Cited by 10,738
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
A Direct Approach to False Discovery Rates
Storey, J. D. (2002) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00346 · Cited by 5,603
More powerful procedures for multiple significance testing
Hochberg, Y., & Benjamini, Y. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090710 · Cited by 2,715
Carlson, C. S., Eberle, M. A., Rieder, M. J., Qian, Y., Kruglyak, L., & Nickerson, D. A. (2004) · The American Journal of Human Genetics · doi:10.1086/381000 · Cited by 1,587
Tanoue, L. T. (2007) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70176-7 · Cited by 1,413
Mackay, J. M., & Eriksen, M. P. (2002) · Medical Entomology and Zoology · Cited by 1,322
Flagged first, then by citations
2 of the 48 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Tapper, 2006, Neuronal nicotinic acetylcholine receptors and nicotine dependence
Cited by
Sorted by citations
Items 301–400 of 851
Bloom, A. J., Baker, T. B., Chen, L.-S., Breslau, N., Hatsukami, D. K., Bierut, L. J., & Goate, A. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt432 · Cited by 36
Self-citationGenetic Variation in the Dopamine Pathway and Smoking Cessation
David, S. P., & Munafo, M. R. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.9.1307 · Cited by 36
MacQueen, D. A., Heckman, B. W., Blank, M. D., Rensburg, K. J. V., Park, J. Y., Drobes, D. J., & Evans, D. E. (2013) · The Pharmacogenomics Journal · doi:10.1038/tpj.2012.50 · Cited by 36
Genome‐wide search for replicable risk gene regions in alcohol and nicotine co‐dependence
Zuo, L., Zhang, F., Zhang, H., Zhang, X., Wang, F., Li, C. R., Lu, L., Jiang, H., Lü, L., Krystal, J. H., et al. (2012) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32047 · Cited by 35
Unraveling the neurobiology of nicotine dependence using genetically engineered mice
Stoker, A. K., & Markou, A. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.02.013 · Cited by 38
Bloom, A. J., Harari, O., Martínez, M., Madden, P. A. F., Martin, N. G., Montgomery, G. W., Rice, J. P., Murphy, S. E., Bierut, L. J., & Goate, A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds114 · Cited by 35
Self-citationMesolimbic Dopamine and Habenulo-Interpeduncular Pathways in Nicotine Withdrawal
Dani, J. A., & De Biasi, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a012138 · Cited by 34
Increased nicotine response in iPSC-derived human neurons carrying the CHRNA5 N398 allele
Oni, E. N., Halikere, A., Li, G., Toro-Ramos, A. J., Swerdel, M. R., Verpeut, J. L., Moore, J. C., Bello, N. T., Bierut, L. J., Goate, A., et al. (2016) · Scientific Reports · doi:10.1038/srep34341 · Cited by 32
Self-citationLassi, G., Taylor, A. E., Mahedy, L., Heron, J., Eisen, T. G., & Munafo, M. R. (2019) · Royal Society Open Science · doi:10.1098/rsos.181133 · Cited by 34
Targeting lung cancer screening to individuals at greatest risk: the role of genetic factors
Lebrett, M. B., Crosbie, E. J., Smith, M. J., Woodward, E. R., Evans, D. G., & Crosbie, P. A. J. (2021) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107399 · Cited by 34
A rare missense mutation in CHRNA4 associates with smoking behavior and its consequences
Thorgeirsson, T. E., Steinberg, S., Reginsson, G. W., Bjornsdottir, G., Rafnar, T., Jonsdottir, I., Helgadottir, A., Gretarsdottir, S., Helgadottir, H., Jonsson, S., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.13 · Cited by 33
Hoft, N. R., Stitzel, J. A., Hutchison, K. E., & Ehringer, M. A. (2010) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2010.00650.x · Cited by 38
McEvoy, C. T., Milner, K. F., Scherman, A. J., Schilling, D., Tiller, C. J., Vuylsteke, B., Shorey‐Kendrick, L. E., Spindel, E. R., Schuff, R. A., Mitchell, J., et al. (2017) · Contemporary Clinical Trials · doi:10.1016/j.cct.2017.05.008 · Cited by 34
Hancock, D. B., Wang, J., Gaddis, N., Levy, J. L., Saccone, N. L., Stitzel, J. A., Goate, A., Bierut, L. J., & Johnson, E. O. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv303 · Cited by 34
Self-citationIn search of causal variants: refining disease association signals using cross-population contrasts
Saccone, N. L., Saccone, S. F., Goate, A., Grucza, R. A., Hinrichs, A. L., Rice, J. P., & Bierut, L. J. (2008) · BMC Genetics · doi:10.1186/1471-2156-9-58 · Cited by 36
Self-citationFiore, M. C., & Baker, T. B. (2009) · American Journal of Public Health · doi:10.2105/ajph.2008.154559 · Cited by 33
ASCL1 Regulates the Expression of the CHRNA5/A3/B4 Lung Cancer Susceptibility Locus
Improgo, M. R., Schlichting, N. A., Cortes, R. Y., Zhao-Shea, R., Tapper, A. R., & Gardner, P. D. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0185 · Cited by 34
Ben‐Eliyahu, A., & Zeidner, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108264822.041 · Cited by 33
Commentary: Gene-environment interactions and smoking-related cancers
Thorgeirsson, T. E., & Stefánsson, K. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyp385 · Cited by 32
Meta-Analyses of Genome-Wide Association Data Hold New Promise for Addiction Genetics
Agrawal, A., Edenberg, H. J., & Gelernter, J. (2016) · Journal of Studies on Alcohol and Drugs · doi:10.15288/jsad.2016.77.676 · Cited by 32
Using Mendelian randomisation to infer causality in depression and anxiety research
Gage, S. H., Smith, G. D., Zammit, S., Hickman, M., & Munafò, M. R. (2013) · Depression and Anxiety · doi:10.1002/da.22150 · Cited by 32
Culverhouse, R., Johnson, E. O., Breslau, N., Hatsukami, D. K., Sadler, B. E., Brooks, A. I., HESSELBROCK, V. M., Schuckit, M. A., Tischfield, J. A., Goate, A., et al. (2014) · Addiction · doi:10.1111/add.12478 · Cited by 32
Self-citationGenetics of biologically based psychological differences
Sallis, H., Smith, G. D., & Munafo, M. R. (2018) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2017.0162 · Cited by 32
Multiple genetic tests for susceptibility to smoking do not outperform simple family history
GARTNER, C. E., Barendregt, J. J., & Hall, W. (2008) · Addiction · doi:10.1111/j.1360-0443.2008.02392.x · Cited by 32
Bidwell, L. C., McGeary, J. E., Gray, J. C., Palmer, R. H. C., Knopik, V. S., & MacKillop, J. M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3748-2 · Cited by 29
GWAS ‐based pathway analysis differentiates between fluid and crystallized intelligence
Christoforou, A., Espeseth, T., Davies, G., Fernandes, C. P. D., Giddaluru, S., Mattheisen, M., Tenesa, A., Harris, S. E., Liewald, D. C. M., Payton, A., et al. (2014) · Genes Brain & Behavior · doi:10.1111/gbb.12152 · Cited by 31
Genetic variation within theChrna7gene modulates nicotine reward‐like phenotypes in mice
Harenza, J., Muldoon, P. P., Biasi, M. D., Damaj, M. I., & Miles, M. F. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12113 · Cited by 35
McEachin, R. C., Saccone, N. L., Saccone, S. F., Kleyman-Smith, Y. D., Kar, T., Kare, R. K., Ade, A. S., Sartor, M. A., Cavalcoli, J. D., & McInnis, M. G. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-14 · Cited by 31
Self-citationAssociation ofCHRNA4polymorphisms with smoking behavior in two populations
Han, S., Yang, B., Kranzler, H. R., Oslin, D. W., Anton, R. F., & Gelernter, J. E. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31177 · Cited by 31
Barrie, E. S., Hartmann, K., Lee, S., Frater, J. T., Seweryn, M. T., Wang, D., & Sadée, W. (2016) · Human Mutation · doi:10.1002/humu.23135 · Cited by 32
Pintarelli, G., Cotroneo, C. E., Noci, S., Dugo, M., Galvan, A., Carpini, S. D., Citterio, L., Manunta, P., Incarbone, M., Tosi, D., et al. (2017) · Scientific Reports · doi:10.1038/srep42185 · Cited by 32
Chen, X. '., Cho, K., Singer, B. H., & Zhang, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016002 · Cited by 32
Verhagen, M., Kleinjan, M., & Engels, R. C. M. E. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.76 · Cited by 32
Compartmentalized Devices as Tools for Investigation of Human Brain Network Dynamics
Fantuzzo, J. A., Hart, R. P., Zahn, J. D., & Pang, Z. P. (2018) · Developmental Dynamics · doi:10.1002/dvdy.24665 · Cited by 31
Uhl, G. R., Drgon, T., Johnson, C., & Liu, Q. (2009) · Journal of Neurogenetics · doi:10.1080/01677060802572929 · Cited by 32
Lotfipour, S., Leonard, G., Perron, M., Pike, B., Richer, L., Séguin, J. R., Toro, R., Veillette, S., Pausova, Z., & Paus, T. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.63 · Cited by 31
Ochoa, V., George, A. A., Nishi, R., & Whiteaker, P. (2015) · The FASEB Journal · doi:10.1096/fj.15-274548 · Cited by 30
Older Smokers' Motivation and Attempts to Quit Smoking
Breitling, L. P., Rothenbacher, D., Stegmaier, C., Raum, E., & Brenner, H. (2009) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2009.0451 · Cited by 30
Olsson, C. A., Moyzis, R. K., Williamson, E., Ellis, J. A., Parkinson-Bates, M., Patton, G. C., Dwyer, T., Romaniuk, H., & Moore, E. E. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00413.x · Cited by 33
Nicotine Withdrawal Symptoms in Adolescent and Adult Twins
Pergadia, M. L., Arpana Agrawal, A., Heath, A. C., Martin, N. G., Bucholz, K. K., & Madden, P. A. F. (2010) · Twin Research and Human Genetics · doi:10.1375/twin.13.4.359 · Cited by 30
Self-citationZhang, H., Kranzler, H. R., Poling, J. C., & Gelernter, J. E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.95 · Cited by 29
Neuroimaging, genetics and the treatment of nicotine addiction
Ray, R., Loughead, J., Wang, Z., Detre, J. A., Yang, E., Gur, R. C., & Lerman, C. E. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.05.021 · Cited by 29
Inclusion of African Americans in Genetic Studies: What Is the Barrier?
Hartz, S. M., Johnson, E. O., Saccone, N. L., Hatsukami, D. K., Breslau, N., & Bierut, L. J. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr084 · Cited by 29
Self-citationSaccone, N. L., Emery, L. S., Sofer, T., Gogarten, S. M., Becker, D. M., Böttinger, E. P., Chen, L.-S., Culverhouse, R., Duan, W., Hancock, D. B., et al. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx107 · Cited by 29
Self-citationDeYoung, C. G., & Blain, S. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108264822.026 · Cited by 34
Cui, K., Ge, X., & Ma, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102324 · Cited by 29
Developmental effects of maternal smoking during pregnancy on the human frontal cortex transcriptome
Semick, S. A., Collado‐Torres, L., Markunas, C. A., Shin, J. H., Deep‐Soboslay, A., Tao, R., Huestis, M. A., Bierut, L. J., Maher, B. S., Johnson, E. O., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0223-1 · Cited by 28
Self-citationNicotine dependence may link the 15q25 locus to lung cancer risk
Galvan, A., & Dragani, T. A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp282 · Cited by 28
Genome-Wide Significant Association Between a Sequence Variant at 15q15.2 and Lung Cancer Risk
Rafnar, Þ., Sulem, P., Besenbacher, S., Gudbjartsson, D. F., Zanon, C., Guðmundsson, J., Stacey, S., Kostic, J. P., Thorgeirsson, T. E., Þorleifsson, G., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2852 · Cited by 28
CYP2B6 rs2279343 polymorphism is associated with smoking cessation success in bupropion therapy
Tomaz, P. R. X., Santos, J. R., Issa, J. S., Abe, T. O., Gaya, P. V., Krieger, J. E., Pereira, A. C., & Santos, P. C. J. L. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1896-x · Cited by 28
Genetics of Smoking Behavior and Its Consequences: The Role of Nicotinic Acetylcholine Receptors
Thorgeirsson, T. E., & Stefánsson, K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.010 · Cited by 27
Curious cases: Altered dose–response relationships in addiction genetics
Uhl, G. R., Drgonová, J., & Hall, F. S. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.10.013 · Cited by 28
Research on Integrative Healthcare: Context and Priorities
Deng, G., Weber, W. J., Sood, A., & Kemper, K. J. (2010) · EXPLORE · doi:10.1016/j.explore.2010.03.007 · Cited by 27
Besson, M., Forget, B., Correia, C., Blanco, R., & Maskos, U. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0462-0 · Cited by 30
Externalizing Behaviors are Associated with SNPs in the CHRNA5/CHRNA3/CHRNB4 Gene Cluster
Stephens, S. H., Hoft, N. R., Schlaepfer, I. R., Young, S. E., Corley, R., McQueen, M. B., Hopfer, C. J., Crowley, T. J., Stallings, M. C., Hewitt, J. K., et al. (2011) · Behavior Genetics · doi:10.1007/s10519-011-9514-x · Cited by 28
Greenbaum, L., Rigbi, A., Lipshtat, N., Cilia, R., Tesei, S., Asselta, R., Djaldetti, R., Goldwurm, S., & Lerer, B. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.07.007 · Cited by 27
The Galanin Receptor 1 Gene Associates with Tobacco Craving in Smokers Seeking Cessation Treatment
Lori, A., Tang, Y., O’Malley, S. S., Picciotto, M. R., Wu, R., Conneely, K. N., & Cubells, J. F. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.25 · Cited by 27
Nees, F., Witt, S. H., Lourdusamy, A., Vollstädt‐Klein, S., Steiner, S., Poustka, L., Banaschewski, T., Barker, G. J., Büchel, C., Conrod, P., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.131 · Cited by 27
Liu, W., & Li, M. D. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170801103009 · Cited by 28
Lee, S., Ahn, W., Seweryn, M. T., & Sadée, W. (2018) · BMC Genomics · doi:10.1186/s12864-018-5219-3 · Cited by 27
Conlon, M. S., & Bewick, M. A. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr140 · Cited by 27
Common polymorphisms in FMO1 are associated with nicotine dependence
Hinrichs, A. L., Murphy, S. E., Wang, J. C. C., Saccone, S. F., Saccone, N. L., Steinbach, J. H., Goate, A., Stevens, V. L., & Bierut, L. J. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328346886f · Cited by 27
Self-citationEnrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
Kar, S., Adler, E. K., Tyrer, J. P., Hazelett, D. J., Anton‐Culver, H., Bandera, E. V., Beckmann, M. W., Berchuck, A., Bogdanova, N. V., Brinton, L. A., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2016.426 · Cited by 25
Role of Genetic Susceptibility in Nicotine Addiction and Chronic Obstructive Pulmonary Disease
Pérez-Rubio, G., Córdoba-Lanús, E., Cupertino, P., Cartujano‐Barrera, F., Campos, M., & Falfán‐Valencia, R. (2019) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.18002617 · Cited by 26
Icick, R., Forget, B., Cloëz-Tayarani, I., Pons, S., Maskos, U., & Besson, M. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108234 · Cited by 31
Cooper, S. Y., & Henderson, B. J. (2020) · Molecules · doi:10.3390/molecules25184223 · Cited by 29
Wen, L., Yang, Z., Cui, W., & Li, M. D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.103 · Cited by 27
Li, P., McCollum, M. M., Bracamontes, J. R., Steinbach, J. H., & Akk, G. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073841 · Cited by 25
A Genetic Deconstruction of Neurocognitive Traits in Schizophrenia and Bipolar Disorder
Fernandes, C. P. D., Christoforou, A., Giddaluru, S., Ersland, K. M., Djurovic, S., Mattheisen, M., Lundervold, A. J., Reinvang, I., Nöthen, M. M., Rietschel, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081052 · Cited by 25
CHRNA5 polymorphisms and risk of lung cancer in Chinese Han smokers.
Huang, C., Xun, X., A-jing, W., Gao, Y., Ma, J., Chen, Y.-T., Jin, T., Hou, P., & Gu, S. (2015) · Europe PMC (PubMed Central) · Cited by 25
Detecting genetic interactions for quantitative traits with U-statistics
Li, M., Ye, C., Fu, W., Elston, R. C., & Lu, Q. L. (2011) · Genetic Epidemiology · doi:10.1002/gepi.20594 · Cited by 25
Adkins, D. E., Daw, J., McClay, J. L., & van den Oord, E. J. C. G. (2012) · Development and Psychopathology · doi:10.1017/s0954579411000824 · Cited by 26
Dash, B., Bhakta, M., Chang, Y., & Lukas, R. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.263673 · Cited by 24
Genetic variants in the MRPS30 region and postmenopausal breast cancer risk
Huang, Y., Ballinger, D. G., Dai, J. Y., Peters, U., Hinds, D. A., Cox, D., Beilharz, E. J., Chlebowski, R. T., Rossouw, J. E., McTiernan, A., et al. (2011) · Genome Medicine · doi:10.1186/gm258 · Cited by 24
Self-citationDu, X., Li, L., Zhang, S., Meng, F., & Zhang, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104960 · Cited by 24
Åberg, K. A., Khachane, A. N., Rudolf, G., Nerella, S., Fugman, D. A., Tischfield, J. A., & van den Oord, E. J. C. G. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.33 · Cited by 24
Self-citationGender-stratified gene and gene–treatment interactions in smoking cessation
Lee, W., Bergen, A. W., Swan, G. E., Li, D., Liu, J., Thomas, P. D., Tyndale, R. F., Benowitz, N. L., Lerman, C., & Conti, D. V. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.30 · Cited by 25
Self-citationFalcone, M., Jepson, C., Benowitz, N. L., Bergen, A. W., Pinto, A., Wileyto, E. P., Baldwin, D. A., Tyndale, R. F., Lerman, C. E., & Ray, R. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr012 · Cited by 26
DRD2/CHRNA5 Interaction on Prefrontal Biology and Physiology during Working Memory
Giorgio, A. D., Smith, R. M., Fazio, L., D’Ambrosio, E., Gelao, B., Tomasicchio, A., Selvaggi, P., Taurisano, P., Quarto, T., Masellis, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095997 · Cited by 24
Arpana Agrawal, A., Pergadia, M. L., Balasubramanian, S., Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Breslau, N., Johnson, E. O., Hatsukami, D. K., Martin, N. G., et al. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02445.x · Cited by 25
Self-citationPreparing the Way: Exploiting Genomic Medicine to Stop Smoking
Bierut, L. J., & Tyndale, R. F. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.12.001 · Cited by 24
Self-citationGenome-Wide Meta-Analyses of FTND and TTFC Phenotypes
Chen, J., Loukola, A., Gillespie, N. A., Peterson, R. E., Jia, P., Riley, B. P., MAES, H. H. M., Dick, D. M., Kendler, K. S., Damaj, M. I., et al. (2019) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntz099 · Cited by 24
Self-citationMaskos, U. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14989 · Cited by 26
Shurtleff, D., Liu, R., & Sasek, C. A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.009 · Cited by 24
From Genes to Treatments: A Systematic Review of the Pharmacogenetics in Smoking Cessation
Salloum, N. C., Buchalter, E. L. F., Chanani, S., Espejo, G. D., Ismail, M. S., Laine, R. O., Nageeb, M., Srivastava, A. B., Trapp, N. T., Trillo, L., et al. (2018) · Pharmacogenomics · doi:10.2217/pgs-2018-0023 · Cited by 26
Pérez-Páramo, Y. X., & Lazarus, P. J. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1863948 · Cited by 25
Reisenzein, R., Hildebrandt, A., & Weber, H. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108264822.009 · Cited by 26
A systems biology network model for genetic association studies of nicotine addiction and treatment
Thomas, P. D., Mi, H., Swan, G. E., Lerman, C. E., Benowitz, N. L., Tyndale, R. F., Bergen, A. W., & Conti, D. V. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832e2ced · Cited by 23
Self-citationFunctional characterization of SNPs in CHRNA3/B4 intergenic region associated with drug behaviors
Flora, A. V., Zambrano, C. A., Gallego, X., Miyamoto, J. H., Johnson, K. A., Cowan, K. A., Stitzel, J. A., & Ehringer, M. A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.07.017 · Cited by 27
Schuck, K., Otten, R., Engels, R. C. M. E., Barker, E. D., & Kleinjan, M. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts082 · Cited by 24
Substance dependence low-density whole genome association study in two distinct American populations
Yu, Y., Kranzler, H. R., Panhuysen, C. I. M., Weiss, R. D., Poling, J. C., Farrer, L. A., & Gelernter, J. E. (2008) · Human Genetics · doi:10.1007/s00439-008-0501-0 · Cited by 23
Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date
Mamoun, M. S., Bergen, A. W., Shieh, J., Wiggins, A., & Brody, A. L. (2015) · CNS Drugs · doi:10.1007/s40263-015-0243-1 · Cited by 24
Saccone, N. L., Baurley, J. W., Bergen, A. W., David, S. P., Elliott, H. R., Foreman, M. G., Kaprio, J. A., Piasecki, T. M., Relton, C. L., Zawertailo, L. A., et al. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx096 · Cited by 23
Self-citationGoldstein, J. A., Bastarache, L. A., Denny, J. C., Roden, D. M., Pulley, J. M., & Aronoff, D. M. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.013 · Cited by 24
One for all and all for One: Improving replication of genetic studies through network diffusion
Lancour, D., Naj, A. C., Mayeux, R. P., Haines, J. L., Pericak‐Vance, M. A., Schellenberg, G. D., Crovella, M. E., Farrer, L. A., & Kasif, S. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007306 · Cited by 24
Intrinsic Insular-Frontal Networks Predict Future Nicotine Dependence Severity
Hsu, L., Keeley, R. J., Liang, X., Brynildsen, J. K., Lu, H., Yang, Y., & Stein, E. A. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0140-19.2019 · Cited by 22
Mobascher, A., Rujescu, D., Mittelstraß, K., Giegling, I., Lamina, C., Nitz, B., Brenner, H., Fehr, C., Breitling, L. P., Gallinat, J., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31011 · Cited by 22
Dizziness and the genetic influences on subjective experiences to initial cigarette use
Haberstick, B. C., Ehringer, M. A., Lessem, J. M., Hopfer, C. J., & Hewitt, J. K. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.03133.x · Cited by 23
Neurocognitive Phenotypes and Genetic Dissection of Disorders of Brain and Behavior
Congdon, E., Poldrack, R. A., & Freimer, N. B. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.007 · Cited by 22
Significant association of CHRNB3 variants with nicotine dependence in multiple ethnic populations
Cui, W., Wang, S., Yang, J., Yi, S. G., Yoon, D., Kim, Y., Payne, T. J., Ma, J. Z., Park, T., & Li, M. D. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.190 · Cited by 23
Metadata
- Authors
- Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A. F., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O., Swan, G. E., Goate, A. M., Rutter, J., Bertelsen, S., Fox, L., Fugman, D., Martin, N. G., Montgomery, G. W., Wang, J. C., Ballinger, D. G., Rice, J. P., & Bierut, L. J.
- Affiliations
- Washington University in St. Louis (US)
- Pennsylvania State University (US)
- Perlegen (United States) (US)
- Michigan State University (US)
- RTI International (US)
- University of Minnesota (US)
- University of Michigan (US)
- SRI International (US)
- National Institute on Drug Abuse (US)
- Rutgers, The State University of New Jersey (US)
- QIMR Berghofer Medical Research Institute (AU)
- Corresponding author
- Saccone, Scott F.
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-11-29
- Volume
- 16
- Issue
- 1
- Pages
- 36-49
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC2270437
- OpenAlex
- W2118320202
- Cited by
- 850
- References
- 48
- Citations by year
- 2026: 6 · 2025: 8 · 2024: 12 · 2023: 20 · 2022: 16 · 2021: 24 · 2020: 65 · 2019: 37 · 2018: 35 · 2017: 35 · 2016: 54 · 2015: 51 · 2014: 48 · 2013: 58 · 2012: 86
- FWCI
- 31.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- National Institute on Drug Abuse (R56DA012854, DA12854, DA015129, N01DA07079, K01DA015129, R01DA012854)
- National Cancer Institute (CA89392, P01CA089392)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Keywords
- nicotine dependence, CHRNA5, single nucleotide polymorphisms, genetic association, genetic susceptibility loci, recessive inheritance, KCNJ6, GABRA4, smoking, Fagerström Test for Nicotine Dependence
- MeSH terms
- Adult, Aged, Aged, 80 and over, Chromosomes, Human, Pair 8, Female, Genetic Markers, Genotype, Humans, Male, Middle Aged, Receptors, Nicotinic, Tobacco Use Disorder, Genetic Variation, Cluster Analysis, Case-Control Studies, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review